Cadila Healthcare gets USFDA nod Fluphenazine Hydrochloride Tablets by admin- Monday, May 31st, 2021 04:42:50 PM
Zydus Cadila has acquired final approval from the USFDA to marketplace Fluphenazine Hydrochloride Tablets in the strengths of one mg, 2.5 mg, 5 mg, and 10 mg (US RLD: Prolixin Tablets). This medication is used to treat symptoms of a sure kind of mental/temper circumstance (schizophrenia). Fluphenazine belongs to a category
of medications referred to as phenothiazines and is also called a neuroleptic.
The drug could be manufactured at the institution’s method manufacturing facility on the SEZ, Ahmedabad. The organization now has 318 approvals and has thus far filed over 400 ANDAs because the graduation of the filing process in FY 2003-04.